Premium
Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream
Author(s) -
Plachouri KerasiaMaria,
Balasis Stauros,
Mallioris Athanasios Fotopoulos,
Koumoundourou Dimitra,
Georgiou Sophia
Publication year - 2018
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12685
Subject(s) - imiquimod , medicine , dermatology , basal cell carcinoma , basal cell , incidence (geometry) , skin cancer , surgery , pathology , cancer , physics , optics
Basal cell carcinoma (BCC) is one of the most frequent skin malignancies, with increasing incidence over the past years. Although the surgical excision is the gold‐standard treatment, several other noninvasive therapies have also been developed for the management of these skin tumors, especially in the cases where a surgical intervention does not seem feasible. Imiquimod is an immunomodulatory agent, which has received approval in the topical treatment of superficial BCCs. With this short report, we present the case of a patient with multifocal pigmented BCCs, successfully treated with topical 5% imiquimod cream.